scholarly journals Sarcoidosis after Antiretroviral Therapy in a Patient with Acquired Immunodeficiency Syndrome

2000 ◽  
Vol 31 (5) ◽  
pp. 1278-1280 ◽  
Author(s):  
V. Gomez ◽  
P. R. Smith ◽  
J. Burack ◽  
R. Daley ◽  
U. Rosa
Keyword(s):  
Antiretroviral Therapy ◽  
Acquired Immunodeficiency Syndrome ◽  
Acquired Immunodeficiency ◽  
Immunodeficiency Syndrome

Risk Factors in Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Patients Undergoing Antiretroviral Therapy in the State of Pernambuco, Brazil: A Case–Control Study

2010 ◽  
Vol 8 (3) ◽  
pp. 271-277 ◽  
Author(s):  
Thais Gelenske ◽  
Francisco Alfredo Bandeira e Farias ◽  
Ricardo Arraes de Alencar Ximenes ◽  
Heloísa Ramos Lacerda de Melo ◽  
Maria de Fátima Pessoa Militão de Albuquerque ◽  
...  
Keyword(s):  
Risk Factors ◽  
Human Immunodeficiency Virus ◽  
Antiretroviral Therapy ◽  
Acquired Immunodeficiency Syndrome ◽  
Case Control Study ◽  
Case Control ◽  
Immunodeficiency Virus ◽  
Acquired Immunodeficiency ◽  
Immunodeficiency Syndrome ◽  
Control Study

Utility of Brain Biopsy in Patients with Acquired Immunodeficiency Syndrome before and after Introduction of Highly Active Antiretroviral Therapy

Neurosurgery ◽  
2007 ◽  
Vol 61 (1) ◽  
pp. 130-141 ◽  
Author(s):  
Joshua M. Rosenow ◽  
Alan Hirschfeld
Keyword(s):  
Antiretroviral Therapy ◽  
Progressive Multifocal Leukoencephalopathy ◽  
Acquired Immunodeficiency Syndrome ◽  
Highly Active Antiretroviral Therapy ◽  
Brain Biopsy ◽  
Karnofsky Performance Score ◽  
Highly Active ◽  
Number Of Patients ◽  
Acquired Immunodeficiency ◽  
Immunodeficiency Syndrome

Abstract OBJECTIVE This study investigates the changing indications, results, and practice patterns of brain biopsy in patients with acquired immunodeficiency syndrome (AIDS) as treatment evolved with the development of highly active antiretroviral therapy (HAART). METHODS We collected data on 246 patients with AIDS who were undergoing brain biopsy of intracranial lesions. Patients were managed in accordance with a uniform protocol. Patients were divided into two groups of those biopsied in the era before (1992–1996) or after (1997–2001) the use of HAART. RESULTS The introduction of HAART led to a steep decrease in the number of biopsies performed annually. The protocol functioned well. Diagnoses were obtained for 92.3% of patients. Lymphoma was the most frequent diagnosis (52.9% of patients), followed by progressive multifocal leukoencephalopathy (18.9% of patients) and toxoplasmosis (8.1% of patients). No patient who underwent lesion biopsy for reasons of negative toxoplasmosis titers or atypical radiology evaluation was diagnosed with toxoplasmosis. Nineteen patients who experienced failed toxoplasmosis treatment were diagnosed with toxoplasmosis. Toxoplasmosis titers had a high specificity and a negative predictive value. Patients with progressive multifocal leukoencephalopathy or nondiagnostic biopsies were more likely to have solitary lesions. The average Karnofsky performance score at the time of biopsy was 72.4, which is still within the range of independent functioning. Significant intracerebral hemorrhages were only observed in patients with lymphoma who also had low platelet counts. CONCLUSION Although the number of patients with AIDS who require brain biopsy has decreased, the procedure still has merits. The paradigm we developed was useful for selecting patients for early biopsy. Patients with AIDS who also have intracerebral lesions should have toxoplasmosis titers performed, and those whose titers are negative for toxoplasmosis should undergo early brain biopsy.

Sign in / Sign up

Export Citation Format

Share Document